Alkermes Plc (ALKS)

Exchange
NASDAQ
Symbol
ALKS
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Alkermes plc, a biopharmaceutical company, researches, develops and markets pharmaceutical products to address the unmet medical needs of patients in various therapeutic areas in the United States, Ireland and internationally. The company is headquartered in Dublin, Ireland.
Country
USA

Stock price

At close: December 20, 2024

  • Open
    29.76
  • High
    30.37
  • Low
    29.53
  • Close
    29.71
  • Volume
    4,636,430

Financial ratios

Sep 30, 2024

Activity ratios
Inventory turnover
3.60
Receivables turnover
4.06
Payables turnover
18.59
Working capital turnover
1.34
Days of inventory on hand (DOH)
101.30
Days of sales outstanding (DSO)
89.80
Number of days of payables
19.63
Fixed asset turnover
6.62
Total asset turnover
0.69
 Liquidity ratios
Current ratio
3.45
Quick ratio
2.81
Cash ratio
2.00
Cash conversion cycle
171.46
 Solvency ratios
Debt-to-assets ratio
0.13
Debt-to-capital ratio
0.18
Debt-to-equity ratio
0.22
Financial leverage ratio
1.67
Interest coverage
12.50
 Profitability ratios
Gross profit margin
29.02%
Operating profit margin
29.25%
Pretax margin
19.22%
Net profit margin
22.33%
Operating return on assets (Operating ROA)
20.25%
Return on assets (ROA)
15.47%
Return on total capital
19.00%
Return on equity (ROE)
25.80%